1,102
Views
20
CrossRef citations to date
0
Altmetric
Short Communication

Combining carbonic anhydrase and thioredoxin reductase inhibitory motifs within a single molecule dramatically increases its cytotoxicity

, , , , , , & ORCID Icon show all
Pages 665-671 | Received 27 Jan 2020, Accepted 19 Feb 2020, Published online: 05 Mar 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (10)

Morteza Abdoli, Alessandro Bonardi, Claudiu T. Supuran & Raivis Žalubovskis. (2023) Investigation of novel alkyl/benzyl (4-sulphamoylphenyl)carbamimidothioates as carbonic anhydrase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Jekaterina Ivanova, Morteza Abdoli, Alessio Nocentini, Raivis Žalubovskis & Claudiu T. Supuran. (2023) 1,2,3-Benzoxathiazine-2,2-dioxides – effective inhibitors of human carbonic anhydrases. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1, pages 225-238.
Read now
Morteza Abdoli, Alessandro Bonardi, Claudiu T. Supuran & Raivis Žalubovskis. (2023) 4-Cyanamidobenzenesulfonamide derivatives: a novel class of human and bacterial carbonic anhydrase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1, pages 156-165.
Read now
Morteza Abdoli, Simone Giovannuzzi, Claudiu T. Supuran & Raivis Žalubovskis. (2022) 4-(3-Alkyl/benzyl-guanidino)benzenesulfonamides as selective carbonic anhydrase VII inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 1568-1576.
Read now
Qianhe Xu & Junmin Zhang. (2022) Novel strategies for targeting the thioredoxin system for cancer therapy. Expert Opinion on Drug Discovery 17:5, pages 437-442.
Read now
Claudiu T. Supuran. (2021) Carbonic anhydrase inhibitors: an update on experimental agents for the treatment and imaging of hypoxic tumors. Expert Opinion on Investigational Drugs 30:12, pages 1197-1208.
Read now
Evgeny Chupakhin & Mikhail Krasavin. (2021) Thioredoxin reductase inhibitors: updated patent review (2017-present). Expert Opinion on Therapeutic Patents 31:8, pages 745-758.
Read now
Claudiu T. Supuran. (2021) Multitargeting approaches involving carbonic anhydrase inhibitors: hybrid drugs against a variety of disorders. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 1702-1714.
Read now
Anna Jastrząb & Elżbieta Skrzydlewska. (2021) Thioredoxin-dependent system. Application of inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 362-371.
Read now
Claudiu T. Supuran. (2020) Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery. Expert Opinion on Drug Discovery 15:6, pages 671-686.
Read now

Articles from other publishers (10)

Morteza Abdoli, Alessandro Bonardi, Niccolò Paoletti, Ashok Aspatwar, Seppo Parkkila, Paola Gratteri, Claudiu T. Supuran & Raivis Žalubovskis. (2023) Inhibition Studies on Human and Mycobacterial Carbonic Anhydrases with N-((4-Sulfamoylphenyl)carbamothioyl) Amides. Molecules 28:10, pages 4020.
Crossref
Jekateri̅na Ivanova, Alessio Nocentini, Kaspars Ta̅rs, Ja̅nis Leita̅ns, Elviss Dvinskis, Andris Kazaks, Ilona Domračeva, Claudiu T. Supuran & Raivis Žalubovskis. (2023) Atropo/Tropo Flexibility: A Tool for Design and Synthesis of Self-Adaptable Inhibitors of Carbonic Anhydrases and Their Antiproliferative Effect. Journal of Medicinal Chemistry 66:8, pages 5703-5718.
Crossref
Sergey V. Baykov, Anton A. Shetnev, Artem V. Semenov, Svetlana O. Baykova & Vadim P. Boyarskiy. (2023) Room Temperature Synthesis of Bioactive 1,2,4-Oxadiazoles. International Journal of Molecular Sciences 24:6, pages 5406.
Crossref
A. Nikitjuka, M. Ozola, L. Jackevica, R. Bobrovs & R. Žalubovskis. (2023) Exploration of 3,4-unsubstituted coumarins as thioredoxin reductase 1 inhibitors for cancer therapy. Organic & Biomolecular Chemistry.
Crossref
Claudiu T. Supuran. 2022. Flavonoids and Phenolics. Flavonoids and Phenolics 298 329 .
Morteza Abdoli, Viviana De Luca, Clemente Capasso, Claudiu T. Supuran & Raivis Žalubovskis. (2022) Benzenesulfonamides Incorporating Hydantoin Moieties Effectively Inhibit Eukaryoticand Human Carbonic Anhydrases. International Journal of Molecular Sciences 23:22, pages 14115.
Crossref
Camelia Bhattacharyya, Surupa Chakraborty & Rajib Sengupta. (2022) NO news: S-(de)nitrosylation of cathepsins and their relationship with cancer. Analytical Biochemistry 655, pages 114872.
Crossref
Laura T. Ferguson, Elizabeth D. Hood, Tea Shuvaeva, Vladimir V. Shuvaev, Maria C. Basil, Zhicheng Wang, Jia Nong, Xiaonan Ma, Jichuan Wu, Jacob W. Myerson, Oscar A. Marcos-Contreras, Jeremy Katzen, Justine M. Carl, Edward E. Morrisey, Edward Cantu, Carlos H. Villa, Samir Mitragotri, Vladimir R. Muzykantov & Jacob S. Brenner. (2022) Dual Affinity to RBCs and Target Cells (DART) Enhances Both Organ- and Cell Type-Targeting of Intravascular Nanocarriers. ACS Nano 16:3, pages 4666-4683.
Crossref
Polina Paramonova, Tatiana Sharonova, Stanislav Kalinin, Evgeny Chupakhin, Alexander Bunev & Mikhail Krasavin. (2022) (E)-3-Arylidene-4-diazopyrrolidine-2,5-diones conveniently elaborated into cytotoxic compounds bearing primary sulfonamide and Michael acceptor moieties. Mendeleev Communications 32:2, pages 176-177.
Crossref
Sizhu Ren, Ruixue Chen, Zhangfei Wu, Shan Su, Jiaxi Hou & Yanlin Yuan. (2021) Enzymatic characteristics of immobilized carbonic anhydrase and its applications in CO2 conversion. Colloids and Surfaces B: Biointerfaces 204, pages 111779.
Crossref